Breast conserving surgery versus mastectomy: overall and relative survival—a population based study by the Danish Breast Cancer Cooperative Group (DBCG)

References

• Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232.
   PubMed Web of Science ®Google Scholar
• Blichert-Toft M, Nielsen M, Düring M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008;47:672–681.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Pappas L, Neumayer L, et al. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;84132:1–8.
   Google Scholar
• Fisher S, Gao H, Yasui Y, et al. Survival in stage I-III breast cancer patients by surgical treatment in a publicly funded health care system. Ann Oncol. 2015;26:1161–1169.
   PubMed Web of Science ®Google Scholar
• Hwang ES, Lichtensztajn DY, Gomez SL, et al. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013;119:1402–1411.
   PubMed Web of Science ®Google Scholar
• Chen K, Liu J, Zhu L, et al. Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: a NCDB analysis. Oncotarget. 2015;6:40127–40140.
   PubMed Web of Science ®Google Scholar
• Johns N, Dixon JM. Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy? Eur J Surg Oncol. 2016;42:1636–1641.
   PubMed Web of Science ®Google Scholar
• Møller S, Jensen M-B, Ejlertsen B, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol. 2008;47:506–524.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343–346.
   PubMedGoogle Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. Available from: https://www.R-project.org/
   Google Scholar
• Hartmann-Johnsen OJ, Kåresen R, Schlichting E, et al. Survival is better after breast conserving therapy than mastectomy for early stage breast cancer: a registry-based follow-up study of Norwegian women primary operated between 1998 and 2008. Ann Surg Oncol. 2015;22:3836–3845.
   PubMed Web of Science ®Google Scholar
• Hofvind S, Holen Å, Aas T, et al. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol. 2015;41:1417–1422.
   PubMed Web of Science ®Google Scholar
• van Maaren MC, de Munck L, Jobsen JJ, et al. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients. Breast Cancer Res Treat. 2016;160:511–521.
   PubMed Web of Science ®Google Scholar
• Lagendijk M, van Maaren MC, Saadatmand S, etet al. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients. Int J Cancer. 2017;142:165–175.
   PubMed Web of Science ®Google Scholar
• Onitilo AA, Engel JM, Stankowski RV, et al. Survival comparisons for breast conserving surgery and mastectomy revisited: community experience and the role of radiation therapy. Clin Med Res. 2015;13:65–73.
   PubMed Web of Science ®Google Scholar
• Laurberg T, Lyngholm CD, Christiansen P, et al. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. Radiother Oncol. 2016;120:98–106.
   PubMed Web of Science ®Google Scholar
• Lyngholm CD, Laurberg T, Alsner J, et al. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort. Acta Oncol. 2016;55:983–992.
   PubMed Web of Science ®Google Scholar
• Laurberg T, Alsner J, Tramm T, et al. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients. Acta Oncol. 2017;56:59–67.
   PubMed Web of Science ®Google Scholar
• Land LH, Dalton SO, Jensen M-B, et al. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat. 2012;131:1013–1020.
   PubMed Web of Science ®Google Scholar
• Bodilsen A, Bjerre K, Offersen BV, et al. The influence of repeat surgery and residual disease on recurrence after breast-conserving surgery: a Danish Breast Cancer Cooperative Group study. Ann Surg Oncol. 2015;22:476–485.
   Web of Science ®Google Scholar
• Olsson Å, Sartor H, Borgquist S, et al. Breast density and mode of detection in relation to breast cancer specific survival: a cohort study. BMC Cancer. 2014;14:229.
   PubMed Web of Science ®Google Scholar
• Bodilsen A, Bjerre K, Offersen BV, et al. Importance of margin width in breast-conserving treatment of early breast cancer. J Surg Oncol. 2016;113:609–615.
   PubMed Web of Science ®Google Scholar
• Tiong LU, Parkyn R, Walters D, et al. Dilemma in multifocal breast cancer - largest versus aggregate diameter. ANZ J Surg. 2011;81:614–618.
   PubMed Web of Science ®Google Scholar
• Wolters R, Wöckel A, Janni W, et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat. 2013;142:579–590.
   PubMed Web of Science ®Google Scholar
• Joergensen LE, Gunnarsdottir KA, Lanng C, et al. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. Breast. 2008;17:587–591.
   PubMed Web of Science ®Google Scholar
• Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous (multifocal and multicentric) breast cancer: clinical implications. Surg Oncol. 2010;19:e115–e123.
   PubMed Web of Science ®Google Scholar
• Ataseven B, Lederer B, Blohmer JU, et al. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2015;22:1118–1127.
   PubMed Web of Science ®Google Scholar
• Jawa RS, Anillo S, Huntoon K, et al. Interleukin-6 in surgery, trauma, and critical care part II: clinical implications. J Intensive Care Med. 2011;26:73–87.
   PubMedGoogle Scholar
• Retsky M, Demicheli R, Hrushesky WJM, et al. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013;20:4163–4176.
   PubMed Web of Science ®Google Scholar
• Demicheli R, Osaro E, Retsky M, et al. Protocol for a randomised, multicentre, double blinded phase III study of perioperative ketorolac in women of African descent with operable breast cancer. Jacobs J Intern Med. 2016;2:17.
   Google Scholar